Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cognetivity Neurosciences Ltd C.CGN

Alternate Symbol(s):  CGNSF

Cognetivity Neurosciences Ltd. is a Canada-based technology company. The Company has developed a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical and commercial environments and other neurological conditions. The Company’s CognICA uses artificial intelligence and machine learning technology to test the performance of large areas of the brain to help... see more

Recent & Breaking News (CSE:CGN)

Cognetivity Neurosciences Enters Asia Via Pilot Agreement with Leading Singaporean Senior Care Network

Canada NewsWire July 5, 2022

Cognetivity Neurosciences CFO to Speak at InterSystems Global Summit in Seattle on June 23, 2022

Canada NewsWire June 20, 2022

Cognetivity Neurosciences CEO to Deliver Keynote Speech at Collision 2022 in Toronto

Canada NewsWire June 16, 2022

Cognetivity Neurosciences Completes Successful Pilot and Enters Commercial Agreement PRIME Health

Canada NewsWire June 15, 2022

Cognetivity Neurosciences Announces Successful Filing of Audited Annual Financial Statements and Lifting of Management Cease Trade Order

Canada NewsWire June 6, 2022

Cognetivity Neurosciences Signs Deployment Agreement with United Arab Emirates' Largest Healthcare Network SEHA

Canada NewsWire June 2, 2022

Cognetivity Neurosciences Announces Management Cease Trade Order

Canada NewsWire June 1, 2022

Cognetivity Neurosciences to Present Research Findings at AAIC 2022 Conference

Canada NewsWire May 31, 2022

Cognetivity Neurosciences to Deploy CognICA(TM) at Beyond Geriatrics Clinic in Florida

Canada NewsWire May 25, 2022

Cognetivity Neurosciences Publishes Peer-Reviewed Article Further Validating Unique Capabilities of its CognICA(TM) Platform for Brain Health Screening

Canada NewsWire May 12, 2022

Cognetivity Neurosciences and Durham University to Study Concussion in Sport

Canada NewsWire May 5, 2022

Cognetivity Neurosciences Shines Member-based Spotlight on the Alzheimer's Association Business Consortium

Canada NewsWire April 20, 2022

Cognetivity Neurosciences Announces Publication of Latest Peer-Reviewed Protocol Paper Reporting on its Accelerating Dementia Pathway (ADePT) Project

Canada NewsWire April 7, 2022

Cognetivity Neurosciences Enters Collaborative Arrangement with PRIME Health

Canada NewsWire March 22, 2022

Cognetivity Neurosciences Wins UAE Innovates Award for 2022

Canada NewsWire March 3, 2022

Cognetivity Neurosciences Reaches Commercial Agreement with Dubai Health Authority

Canada NewsWire March 2, 2022

Cognetivity Neurosciences Closes Final Tranche of Unit Offering

Canada NewsWire February 24, 2022

Cognetivity Neurosciences Closes Second Tranche of Unit Offering

PR Newswire February 11, 2022

Cognetivity Neurosciences Reaches Commercial Agreement with Emirates Health Services

PR Newswire February 1, 2022

Cognetivity Neurosciences Closes First Tranche of Unit Offering

PR Newswire January 28, 2022